Symposium to co-ordinate fight against cancer
30 August 2002 - 30 August 2002
Three of the world's leading organisations are joining forces in Frankfurt from 19 to 22 November to provide a platform for presentation of the latest findings in drug research and development to around 2,000 international experts in the field.
The revolution in understanding the molecular basis of cancer has lead to the discovery and development of numerous innovative agents - 'designer' diagnostics, new prognostic tests, 'smart' drugs and other entirely novel ways of tackling cancer.
To bring these new developments to patients as quickly and efficiently as possible requires international collaboration, early and optimal exchange of information, good quality transnational research, efficient drug development and large prospective clinical trials.
The European organisation for research and treatment of cancer, the USA's National cancer institute and the American association for cancer research will be presenting previously unpublished findings at the four day symposium.More information on the programme is available on the EORTC website: http://www.eortc.be(opens in new window)
The revolution in understanding the molecular basis of cancer has lead to the discovery and development of numerous innovative agents - 'designer' diagnostics, new prognostic tests, 'smart' drugs and other entirely novel ways of tackling cancer.
To bring these new developments to patients as quickly and efficiently as possible requires international collaboration, early and optimal exchange of information, good quality transnational research, efficient drug development and large prospective clinical trials.
The European organisation for research and treatment of cancer, the USA's National cancer institute and the American association for cancer research will be presenting previously unpublished findings at the four day symposium.More information on the programme is available on the EORTC website: http://www.eortc.be(opens in new window)